• no-js

The mission of the MRC Weatherall Institute of Molecular Medicine (WIMM) is to undertake internationally competitive research into the processes underlying normal cell and molecular biology and to determine the mechanisms by which these processes are perturbed in inherited and acquired human diseases. It is also our mission to translate this research to improve human health. The WIMM is uniquely placed among biomedical institutes throughout the world in its pioneering vision of combining outstanding clinical research with excellent basic science. The WIMM Faculty currently includes an equal mixture of scientists and clinicians working together and in collaboration with the National Institute of Health Research, the NHS and commercial companies with the aim of improving the diagnosis and treatment of human diseases. The major topics of current research include haematology, immunology, stem cell biology, oncology and inherited human genetic diseases. The Institute benefits from strategic support from the MRC.

MRC logo

The Institute values communication with members of the broader scientific community and the general public and with the support of the Medical Research Council (MRC) we have commissioned three short videos to explain our mission.

News

Defining the role of lipids in skin inflammation

Defining the role of lipids in skin inflammation

Posted 16/02/2018

  Congratulations to Prof Graham Ogg who has been awarded a Wellcome Trust Collaborative Award to investigate aspects of the immune response in skin diseases such as eczema, with the hope of identifying new treatment options.   Skin diseases, such as eczema and psoriasis, are very common and carry an enormous burden on patients, families and the NHS. Nevertheless, the immunological mechanisms underlying the maintenance and function of human ...

 

New international collaborative network to study β-thalassaemia

New international collaborative network to study β-thalassaemia

Posted 15/02/2018

  A new grant from the UK Academy of Medical Sciences will allow clinicians and scientists from Oxford, Sri Lanka and Thailand to establish new ties to support research into β thalassaemia and benefit those most affected. β-Thalassaemia is a type of anaemia where a faulty gene leads to misproduction of haemoglobin in red blood cells. No cure is available, except for rare cases where a suitable bone marrow donor can be found. The disease ...

News Archive

 

Vacancies

Postdoctoral Scientist in Haematopoietic Stem Cell Biology ref.133665

Posted 16/02/2018

This is a unique opportunity for a driven, highly motivated and ambitious Postdoctoral Scientist to join the research group of Professor Adam Mead at the MRC Weatherall Institute of Molecular Medicine (WIMM) to use a number of state-of-the-art molecular and cellular techniques to investigate the role of megakaryocytes in myeloproliferative neoplasms. The position is available fixed-term until 28 February 2021, funded by Bloodwise.  The Mead ...

Other Vacancies

WIMM Blog

Breaking the link- how robust are gene expression networks?

Underground image

The intricate biological cascades that fine-tune cellular protein production are hugely complex – and so is the task of deciphering them. We found out more about a new technique developed in the Fulga lab to disentangle this regulatory web.

WIMM Blog Archive